Mercosur plans diagnostics and reagents production
This article was originally published in Clinica
Science and technology experts and healthcare policy-makers from across South America met this week in Brazil to discuss the potential roles of the Mercosur trading bloc in the production of diagnostics and reagents.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.